Health-related quality of life and treatment burden in patients with proliferative lupus nephritis treated with cyclophosphamide or azathioprine/ methylprednisolone in a randomized controlled trial.

C. Grootscholten; F.J. Snoek; M. Bijl; HC van Houwelingen; R.H.W.M. Derksen; J.H. Berden

Health-related quality of life and treatment burden in patients with proliferative lupus nephritis treated with cyclophosphamide or azathioprine/ methylprednisolone in a randomized controlled trial.

Translated title of the contribution: Health-related quality of life and treatment burden in patients with proliferative lupus nephritis treated with cyclophosphamide or azathioprine/ methylprednisolone in a randomized controlled trial.

C. Grootscholten, F.J. Snoek, M. Bijl, HC van Houwelingen, R.H.W.M. Derksen, J.H. Berden

Rheumatology & Clinical Immunology

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Health-related quality of life and treatment burden in patients with proliferative lupus nephritis treated with cyclophosphamide or azathioprine/ methylprednisolone in a randomized controlled trial.
Original language	Undefined/Unknown
Pages (from-to)	1699-1707
Number of pages	9
Journal	Journal of Rheumatology
Volume	34
Issue number	8
Publication status	Published - 2007

Cite this

@article{4aa81d29af4146d0a7ac5cc1aa0b344d,

title = "Health-related quality of life and treatment burden in patients with proliferative lupus nephritis treated with cyclophosphamide or azathioprine/ methylprednisolone in a randomized controlled trial.",

author = "C. Grootscholten and F.J. Snoek and M. Bijl and {van Houwelingen}, HC and R.H.W.M. Derksen and J.H. Berden",

year = "2007",

language = "Undefined/Unknown",

volume = "34",

pages = "1699--1707",

journal = "Journal of Rheumatology",

issn = "0315-162X",

publisher = "Journal of Rheumatology",

number = "8",

}

Health-related quality of life and treatment burden in patients with proliferative lupus nephritis treated with cyclophosphamide or azathioprine/ methylprednisolone in a randomized controlled trial. / Grootscholten, C.; Snoek, F.J.; Bijl, M. et al.
In: Journal of Rheumatology, Vol. 34, No. 8, 2007, p. 1699-1707.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Health-related quality of life and treatment burden in patients with proliferative lupus nephritis treated with cyclophosphamide or azathioprine/ methylprednisolone in a randomized controlled trial.

AU - Grootscholten, C.

AU - Snoek, F.J.

AU - Bijl, M.

AU - van Houwelingen, HC

AU - Derksen, R.H.W.M.

AU - Berden, J.H.

PY - 2007

Y1 - 2007

M3 - Article

SN - 0315-162X

VL - 34

SP - 1699

EP - 1707

JO - Journal of Rheumatology

JF - Journal of Rheumatology

IS - 8

ER -